Defibrillators Market Size to Reach USD 21.54 Billion by 2028

The defibrillators market size was estimated at USD 12.65 billion in 2022 and is forecast to reach USD 21.54 billion in 2028. The market is projected to grow at a 9.18% CAGR between 2023 and 2028. Its expansion reflects the growing importance of defibrillation in cardiac emergencies and increasing availability of devices across healthcare and public-access environments. 

The defibrillators market is expected to grow at a CAGR of 9.18% during 2023-2028. The source connects market development with cardiovascular diseases, cardiac arrest, arrhythmias, technology development, awareness initiatives, government measures, and healthcare infrastructure expansion. Together, these stated factors create demand across multiple clinical and non-clinical settings. 

The market structure shows a clear role for both implantable and external technologies. Implantable devices represented the larger type segment in 2022, while external defibrillators posted the fastest CAGR. This contrast highlights the importance of evaluating both current market size and forward growth rates when assessing the industry. 

The defibrillators market size is therefore best viewed through its segment structure rather than headline value alone. End-user demand spans hospitals, clinics, cardiac centers, prehospital settings, public access markets, alternate care facilities, and home care facilities, creating a broad demand base.

Request a free sample report: https://www.stratviewresearch.com/Request-Sample/defibrillators-market#form

Market Segmentation Analysis

By Type, the defibrillators market is segmented into Implantable Cardioverter Defibrillators and External Defibrillators. The ICDs segment held more than 65% of the market in 2022. External defibrillators recorded the fastest CAGR of nearly 9.2% during the forecast period. The source links ICD performance with technologically enhanced devices, extended life spans, increasing implant procedures, and adoption of CRT-D and S-ICD systems. 

By End-User Type, the market is segmented into Hospitals, Clinics, and Cardiac Centers; Prehospital Care Settings; Public Access Markets; Alternate Care Facilities; and Home Care Facilities. Hospitals, clinics, and cardiac centers captured the largest share in 2022, with hospitals accounting for more than 75%. The public access market recorded a CAGR of nearly 9.5%. 

Regional Market Insights

North America represented the largest regional market, accounting for more than 30% in 2022. The region is expected to retain its dominance during the forecast period, supported by the increasing geriatric population, growing cardiac disease incidents, and technological advancements identified by the source. 

Asia-Pacific and Europe are expected to provide substantial growth opportunities during the forecast period. The source identifies both regions as important areas for market expansion, without stating that either region exceeds North America in market share. 

Emerging Trends Shaping the Defibrillators Market

One significant industry direction is the development of technologically enhanced defibrillators. The source specifically connects improved technology and extended device life spans with the strong position of implantable cardioverter defibrillators, while CRT-D and S-ICD adoption also contributes to this segment's market position. 

External defibrillators represent another important growth direction. Their nearly 9.2% CAGR during the forecast period is higher than the overall market CAGR, while public access markets are also expected to grow at nearly 9.5%, according to the source. 

Key Growth Drivers of the Market

• Cardiac emergencies: Defibrillators are vital life-saving tools for cardiac arrest and arrhythmias, creating fundamental demand for the technology. 

• Device technology: Technological development has contributed to market growth and improved the ease of use of automated external defibrillators. 

• Public awareness: Awareness campaigns and training initiatives reinforce the importance of early defibrillation and support demand for accessible devices. 

• Public-space deployment: Defibrillator availability is being expanded across airports, retail centers, sporting venues, and transit hubs, broadening the market ecosystem. 

• Healthcare access: Developing healthcare infrastructure and increased healthcare costs are supporting demand from hospitals, clinics, and ambulatory care centers. 

Competitive Landscape

Top Companies in the Market

• Biotronik  

• Boston Scientific 

• CU Medical Systems, Inc. 

• Koninklijke Philips N.V. 

• Mediana  

• Medtronic plc 

• Metsis Medikal 

• Microport  

• Mindray Medical 

• Nihon Kohden 

Conclusion and Strategic Outlook

The defibrillators market size is projected to rise from USD 12.65 billion in 2022 to USD 21.54 billion in 2028. The 9.18% CAGR indicates a sustained growth trajectory shaped by cardiac emergency needs, technology development, public awareness, government measures, and healthcare infrastructure. 

Segment performance adds important context. ICDs held the larger share in 2022, while external defibrillators showed faster growth. North America remains the largest region, with Asia-Pacific and Europe offering substantial growth opportunities.

FAQs – Defibrillators Market

1. What is the current and forecast market size?

The defibrillators market was valued at USD 12.65 billion in 2022. It is projected to reach USD 21.54 billion by 2028. 

2. What CAGR is expected?

The market is projected to grow at a 9.18% CAGR during 2023-2028. The forecast indicates continued expansion across major market segments. 

3. What factors support market growth?

Cardiovascular diseases, technology development, public awareness, government measures, and healthcare infrastructure development are stated market drivers. 

4. Which region has the largest demand?

North America held more than 30% of the market in 2022 and is expected to retain its dominance. Asia-Pacific and Europe are also identified as substantial growth opportunities. 

5. What factors should influence strategic assessment?

Technology development, segment growth, healthcare infrastructure, public accessibility, and competitive dynamics are important factors identified in the source's market assessment.